Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation.

[1]  W. Rand,et al.  Gender-based differences in brachial artery flow-mediated vasodilation as an indicator of significant coronary artery disease. , 2005, The American journal of cardiology.

[2]  Rudolf Berger,et al.  Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide. , 2005, Journal of the American College of Cardiology.

[3]  J. Lekakis,et al.  Increased circulating C-reactive protein and macrophage-colony stimulating factor are complementary predictors of long-term outcome in patients with chronic coronary artery disease. , 2005, European heart journal.

[4]  J. Lekakis,et al.  Rapid effect of pravastatin on endothelial function and lipid peroxidation in unstable angina. , 2005, International journal of cardiology.

[5]  S. Fichtlscherer,et al.  Prognostic Value of Systemic Endothelial Dysfunction in Patients With Acute Coronary Syndromes: Further Evidence for the Existence of the “Vulnerable” Patient , 2004, Circulation.

[6]  Massimo Chiariello,et al.  Endothelial Dysfunction and Cardiovascular Risk Prediction in Peripheral Arterial Disease: Additive Value of Flow-Mediated Dilation to Ankle-Brachial Pressure Index , 2003, Circulation.

[7]  A. Ignaszewski,et al.  The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. , 2003, Journal of the American College of Cardiology.

[8]  D. Yavuz,et al.  Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients , 2003, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[9]  R. Karas,et al.  Clinical Utility of Endothelial Function Testing: Ready for Prime Time? , 2003, Circulation.

[10]  Amir Lerman,et al.  Coronary Endothelial Dysfunction Is Associated With an Increased Risk of Cerebrovascular Events , 2003, Circulation.

[11]  Michael T. Watkins,et al.  Predictive value of noninvasivelydetermined endothelial dysfunction for long-term cardiovascular events inpatients with peripheral vascular disease , 2003 .

[12]  K. Prasad,et al.  Suppression of Oxidative Stress as a Mechanism of Reduction of Hypercholesterolemic Atherosclerosis by Aspirin , 2003, Journal of cardiovascular pharmacology and therapeutics.

[13]  F. Coppi,et al.  Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. , 2002, Journal of the American College of Cardiology.

[14]  J. Keaney,et al.  Endothelial function: a barometer for cardiovascular risk? , 2002, Circulation.

[15]  A. Quyyumi,et al.  Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.

[16]  F. Neumann,et al.  Women do have an improved long-term outcome after non-ST-elevation acute coronary syndromes treated very early and predominantly with percutaneous coronary intervention: a prospective study in 1,450 consecutive patients. , 2002, Journal of the American College of Cardiology.

[17]  M. Watkins,et al.  Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial Function: A Prospective Study , 2002, Circulation.

[18]  E. Benjamin,et al.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.

[19]  T. Meinertz,et al.  Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.

[20]  F. Perticone,et al.  Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients , 2001, Circulation.

[21]  K. Kostner,et al.  Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. , 2000, The American journal of cardiology.

[22]  A M Zeiher,et al.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.

[23]  S. Higano,et al.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.

[24]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[25]  A. Yeung,et al.  Close relation of endothelial function in the human coronary and peripheral circulations. , 1995, Journal of the American College of Cardiology.

[26]  D. Collett.  Modelling Survival Data in Medical Research , 1994 .

[27]  D. Schoenfeld,et al.  Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. , 1982, Biometrics.